NasdaqGM - Delayed Quote • USD
Xencor, Inc. (XNCR)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 4:20 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 12 | 12 |
| Avg. Estimate | -0.79 | -0.8 | -3.33 | -2.94 |
| Low Estimate | -1.15 | -1.1 | -4.31 | -4.05 |
| High Estimate | -0.47 | -0.51 | -2.07 | 0.34 |
| Year Ago EPS | -1.02 | -0.37 | -2.08 | -3.33 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 12 | 12 |
| Avg. Estimate | 24.99M | 24.52M | 98.67M | 147.58M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | 48.5M | 48.5M | 194M | 413.33M |
| Year Ago Sales | 18.96M | 45.52M | 168.34M | 98.67M |
| Sales Growth (year/est) | 31.80% | -46.10% | -41.40% | 49.60% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.66 | -0.8 | -0.73 | -0.09 |
| EPS Actual | -1.02 | -0.37 | -0.4 | -0.31 |
| Difference | -0.36 | 0.43 | 0.33 | -0.22 |
| Surprise % | -54.50% | 53.80% | 45.20% | -244.40% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.79 | -0.8 | -3.33 | -2.94 |
| 7 Days Ago | -0.77 | -0.77 | -3.22 | -2.84 |
| 30 Days Ago | -0.77 | -0.77 | -3.21 | -2.84 |
| 60 Days Ago | -0.93 | -0.9 | -3.78 | -2.56 |
| 90 Days Ago | -0.93 | -0.9 | -3.78 | -2.56 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | 1 | 1 | -- |
Growth Estimates
| CURRENCY IN USD | XNCR | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 22.50% | -- | -- | 1.60% |
| Next Qtr. | -116.20% | -- | -- | 10.50% |
| Current Year | -60.10% | -- | -- | 5.20% |
| Next Year | 11.70% | -- | -- | 13.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.22% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Maintains | BTIG: Buy to Buy | 4/16/2024 |
| Downgrade | Piper Sandler: Overweight to Neutral | 2/28/2024 |
| Reiterates | RBC Capital: Outperform to Outperform | 2/28/2024 |
| Maintains | BMO Capital: Outperform to Outperform | 2/28/2024 |
| Maintains | Wedbush: Outperform to Outperform | 2/28/2024 |
| Maintains | Mizuho: Buy to Buy | 1/22/2024 |
Related Tickers
INBX Inhibrx, Inc.
34.32
-0.38%
XENE Xenon Pharmaceuticals Inc.
39.88
-1.07%
ANAB AnaptysBio, Inc.
19.87
+0.20%
MORF Morphic Holding, Inc.
27.99
+1.74%
PTGX Protagonist Therapeutics, Inc.
25.61
+1.55%
IMCR Immunocore Holdings plc
55.68
+1.72%
IDYA IDEAYA Biosciences, Inc.
37.13
-1.30%
CRGX CARGO Therapeutics, Inc.
19.19
+0.47%
MGNX MacroGenics, Inc.
15.61
-2.86%
BCYC Bicycle Therapeutics plc
23.45
-4.25%